Amgen And Allergan Present Phase 3 Data On Biosimilar Trastuzumab Candidate ABP 980 At The European Society For Medical Oncology 2017 Congress

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/19/2026

1. SPY
2. XENE
3. NUE
4. HUBS
5. RTB
6. ONON
7. AAPL
8. TRMD
9. ACN
10. AZN

Go back to Amgen And Allergan Present Phase 3 Data On Biosimilar Trastuzumab Candidate ABP 980 At The European Society For Medical Oncology 2017 Congress
Allergan Inc (NYSE: AGN) Delayed: 193.02 --0 (-0%)
Previous Close $193.02    52 Week High $322.68 
Open $15.33    52 Week Low $186.34 
Day High $193.02    P/E 45.96 
Day Low $193.02    EPS $4.20 
Volume 43,377       

Amgen Inc (NASDAQ: AMGN) Delayed: 385.65 +5.87 (1.55%)
Previous Close $379.78    52 Week High $176.85 
Open $378.51    52 Week Low $133.64 
Day High $386.50    P/E 58.08 
Day Low $378.51    EPS $6.64 
Volume 8,528,108       

DIAGEO PLC (NYSE: DEO) Delayed: 85.59 -1.13 (1.3%)
Previous Close $86.72    52 Week High $117.95 
Open $85.97    52 Week Low $99.46 
Day High $86.22    P/E N/A 
Day Low $85.52    EPS $0.00 
Volume 985,207       

(AMEX: DGE) Delayed: 0.00 -440.99 (100%)
Previous Close $440.99    52 Week High $ 
Open $440.99    52 Week Low $ 
Day High $440.99    P/E N/A 
Day Low $440.99    EPS $ 
Volume 0